SCHEMBL8076310

SCHEMBL8076310

CC(=O)C(Cc1cccc(Cl)c1Cl)C(C)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.48
TAAR1 Q96RJ0 1/20 0.44
IDO1 P14902 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
SLC6A2 P23975 4/20 0.41
SLC6A4 P31645 4/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SLC6A3 Q01959 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
KCNH2 Q12809 1/20 0.40
CTSG P08311 1/20 0.40
CMA1 P23946 1/20 0.40
PTPRC P08575 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21526090 0.85 NPC1 (0.48) PNMTIDO1KMT2ASLC6A2SLC6A4
SCHEMBL14720120 0.80 PNMT (0.41) PNMTTAAR1IDO1MEN1KMT2A
SCHEMBL28876911 0.80 PPARG (0.51) MEN1KMT2ASMN1; SMN2
SCHEMBL15783026 0.79 NR3C1 (0.45) IDO1SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL8984622 0.79 PNMT (0.54) PNMTTAAR1IDO1MEN1KMT2A
SCHEMBL5067377 0.77 PNMT (0.48) PNMTTAAR1IDO1TAS1R3TAS1R1
SCHEMBL18567935 0.77 PNMT (0.52) PNMTTAAR1IDO1SLC6A2SLC6A4
SCHEMBL5805934 0.77 PNMT (0.52) PNMTTAAR1IDO1SLC6A2SLC6A4
SCHEMBL5018770 0.76 PNMT (0.56) PNMTTAAR1IDO1SLC6A2SLC6A4
SCHEMBL17653888 0.75 NOS3 (0.50) PNMTTAAR1IDO1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0758647-B1 Acyl substituted aminopyrans with a modulating effect on calcium channels BAYER AG (DE) 2000-11-02 EP disclosed
US-5719181-A TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-02-17 US disclosed
EP-0758647-A1 Acyl substituted aminopyrans with a modulating effect on calcium channels BAYER AG (DE) 1997-02-19 EP disclosed